MedTrace Logo

Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients

NCT01727024 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2017-01-24

Study results available
· View outcomes & findings →

Summary

This study compared the correct use of and patient preference for two drug delivery systems (inhalers) in patients with COPD

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG

Tiotropium

Tiotropium via Respimat® device once a day

DRUG

Indacaterol

Indacaterol via Breezhaler® device once a day

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis Pharmaceuticals

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01727024 on ClinicalTrials.gov